Your browser doesn't support javascript.
loading
No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study.
Hill, Rachel C; Wang, Yu; Shaikh, Bilal; Lipner, Shari R.
Affiliation
  • Hill RC; Weill Cornell Medical College, New York, New York.
  • Wang Y; Department of Dermatology, Wake Forest School of Medicine, Wake Forest, North Carolina.
  • Shaikh B; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
  • Lipner SR; Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.
J Am Acad Dermatol ; 90(6): 1302-1304, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38423468
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases / Spironolactone / Breast Neoplasms / Genital Neoplasms, Female Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases / Spironolactone / Breast Neoplasms / Genital Neoplasms, Female Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2024 Document type: Article Country of publication: Estados Unidos